Search Results - "WONG, B. C. Y."

Refine Results
  1. 1

    Traditional Chinese medicine causing hepatotoxicity in patients with chronic hepatitis B infection: a 1‐year prospective study by YUEN, M.‐F., TAM, S., FUNG, J., WONG, D. K.‐H., WONG, B. C.‐Y., LAI, C.‐L.

    Published in Alimentary Pharmacology and Therapeutics (01-10-2006)
    “…Summary Background Safety of traditional Chinese medicine in patients with chronic hepatitis B is unknown. Aim To study the clinical outcome of traditional…”
    Get full text
    Journal Article
  2. 2

    Prevalence, clinical spectrum and health care utilization of gastro‐oesophageal reflux disease in a Chinese population: a population‐based study by Wong, W. M., Lai, K. C., Lam, K. F., Hui, W. M., Hu, W. H. C., Lam, C. L. K., Xia, H. H. X., Huang, J. Q., Chan, C. K., Lam, S. K., Wong, B. C. Y.

    Published in Alimentary pharmacology & therapeutics (15-09-2003)
    “…Summary Background : Population‐based data on gastro‐oesophageal reflux disease in Chinese are lacking. The prevalence, clinical spectrum and health…”
    Get full text
    Journal Article
  3. 3

    Clinical features, biochemical parameters, and virological profiles of patients with hepatocellular carcinoma in Hong Kong by CHEUNG, T.‐K., LAI, C.‐L., WONG, B. C.‐Y., FUNG, J., YUEN, M.‐F.

    Published in Alimentary pharmacology & therapeutics (01-08-2006)
    “…Summary Background  Clinical features of hepatocellular carcinoma patients are changing because of screening. Aim  To examine the clinical features of…”
    Get full text
    Journal Article
  4. 4

    Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second‐line treatment of resistant Helicobacter pylori infection by WONG, W. M., GU, Q., CHU, K.‐M., YEE, Y. K., FUNG, F. M. Y., TONG, T. S. M., CHAN, A. O. O., LAI, K. C., CHAN, C. K., WONG, B. C. Y.

    Published in Alimentary pharmacology & therapeutics (01-02-2006)
    “…Summary Aim To test the efficacy of levofloxacin‐based second‐line therapy for resistant Helicobacter pylori infection. Methods One hundred and six patients…”
    Get full text
    Journal Article
  5. 5

    Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second‐line treatment for Helicobacter pylori infection by Wong, W. M., Gu, Q., Lam, S. K., Fung, F. M. Y., Lai, K. C., Hu, W. H. C., Yee, Y. K., Chan, C. K., Xia, H. H. X., Yuen, M. F., Wong, B. C. Y.

    Published in Alimentary pharmacology & therapeutics (01-02-2003)
    “…Summary Aim : To test the efficacy of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy for the second‐line treatment of…”
    Get full text
    Journal Article
  6. 6

    Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician‐referred uninvestigated dyspeptic patients in Hong Kong by XIA, B., XIA, H. H. X., MA, C. W., WONG, K. W., FUNG, F. M. Y., HUI, C. K., CHAN, C. K., CHAN, A. O. O., LAI, K. C., YUEN, M. F., WONG, B. C. Y.

    Published in Alimentary pharmacology & therapeutics (01-08-2005)
    “…Summary Background:  Peptic ulcer disease is mainly caused by Helicobacter pylori infection and the use of non‐steroidal anti‐inflammatory drugs. Aim:  To…”
    Get full text
    Journal Article
  7. 7

    Silencing of Jagged1 inhibits cell growth and invasion in colorectal cancer by Dai, Y, Wilson, G, Huang, B, Peng, M, Teng, G, Zhang, D, Zhang, R, Ebert, M P A, Chen, J, Wong, B C Y, Chan, K W, George, J, Qiao, L

    Published in Cell death & disease (10-04-2014)
    “…Dysregulated Notch signaling has a critical role in the tumorigenesis. Jagged1, a Notch ligand, is overexpressed in various human cancers. Recent studies…”
    Get full text
    Journal Article
  8. 8

    Outcome of emergency ERCP for acute cholangitis in patients 90 years of age and older by Hui, C.‐K., Liu, C.‐L., Lai, K.‐C., Chan, S.‐C., Hu, W. H. C., Wong, W.‐M., Cheung, W. W., Ng, M., Yuen, M.‐F., Chan, A. O., Lo, C. M., Fan, S.‐T., Wong, B. C. Y.

    Published in Alimentary pharmacology & therapeutics (01-06-2004)
    “…Summary Background : An increasing proportion of the general population across the Western World now survives to an advanced age. However, there is limited…”
    Get full text
    Journal Article
  9. 9

    Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer by Chan, A O-O, Lam, S-K, Wong, B C-Y, Wong, W-M, Yuen, M-F, Yeung, Y-H, Hui, W-M, Rashid, A, Kwong, Y-L

    Published in Gut (01-04-2003)
    “…Background:E-cadherin is an adhesion molecule involved in tumour invasion/metastasis. Silencing of E-cadherin by promoter CpG methylation has been shown in…”
    Get full text
    Journal Article
  10. 10

    Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation by Chan, A O O, Peng, J Z, Lam, S K, Lai, K C, Yuen, M F, Cheung, H K L, Kwong, Y L, Rashid, A, Chan, C K, Wong, B C-Y

    Published in Gut (01-04-2006)
    “…Background: E-cadherin methylation is important in gastric carcinogenesis. Reversing hypermethylation may halt the carcinogenic process. We have previously…”
    Get full text
    Journal Article
  11. 11

    Stability of E‐cadherin methylation status in gastric mucosa associated with histology changes by CHAN, A. O. O., HUANG, C., HUI, W. M., CHO, C. H., YUEN, M. F., LAM, S. K., RASHID, A., WONG, B. C.‐Y.

    Published in Alimentary pharmacology & therapeutics (01-09-2006)
    “…Summary Background We have previously shown reversal of E‐cadherin methylation in gastric mucosa from patients with dyspepsia at week 6 after Helicobacter…”
    Get full text
    Journal Article
  12. 12

    Anxiety but not depression determines health care‐seeking behaviour in Chinese patients with dyspepsia and irritable bowel syndrome: a population‐based study by Hu, W. H. C., Wong, W.‐M., Lam, C. L. K., Lam, K. F., Hui, W. M., Lai, K. C., Xia, H. X. H., Lam, S. K., Wong, B. C. Y.

    Published in Alimentary pharmacology & therapeutics (01-12-2002)
    “…Summary Aims : To study the prevalence of dyspepsia and irritable bowel syndrome and the effects of co‐existing anxiety and depression on health care…”
    Get full text
    Journal Article
  13. 13

    Clopidogrel plus omeprazole compared with aspirin plus omeprazole for aspirin‐induced symptomatic peptic ulcers/erosions with low to moderate bleeding/re‐bleeding risk — a single‐blind, randomized controlled study by Ng, F.‐H., Wong, B. C.‐Y., Wong, S.‐Y., Chen, W.‐H., Chang, C.‐M.

    Published in Alimentary pharmacology & therapeutics (01-02-2004)
    “…Summary Background : Clopidogrel causes significantly less symptomatic peptic ulcer disease and gastrointestinal bleeding than low‐dose aspirin in average‐risk…”
    Get full text
    Journal Article
  14. 14

    Positive association between gastro‐oesophageal reflux disease and irritable bowel syndrome in a Chinese population by CHEUNG, T. K., LAM, K. F., HU, W. H. C., LAM, C. L. K., WONG, W. M., HUI, W. M., LAI, K. C., LAM, S. K., WONG, B. C. Y

    Published in Alimentary pharmacology & therapeutics (01-05-2007)
    “…Summary Background Gastro‐oesophageal reflux disease and irritable bowel syndrome are common diseases which may be related. Aim To examine the association…”
    Get full text
    Journal Article
  15. 15

    Long‐term prospective follow‐up of endoscopic oesophagitis in southern Chinese — prevalence and spectrum of the disease by Wong, W.‐M., Lam, S. K., Hui, W. M., Lai, K. C., Chan, C. K., Hu, W. H. C., Xia, H. H. X., Hui, C. K., Yuen, M. F., Chan, A. O. O., Wong, B. C. Y.

    Published in Alimentary pharmacology & therapeutics (01-12-2002)
    “…Summary Aims : To study the prevalence, clinical characteristics and long‐term outcome of oesophagitis in Chinese patients. Methods : Clinical and endoscopic…”
    Get full text
    Journal Article
  16. 16

    A validated symptoms questionnaire (Chinese GERDQ) for the diagnosis of gastro‐oesophageal reflux disease in the Chinese population by Wong, W. M., Lam, K. F., Lai, K. C., Hui, W. M., Hu, W. H. C., Lam, C. L. K., Wong, N. Y. H., Xia, H. H. X., Huang, J. Q., Chan, A. O. O., Lam, S. K., Wong, B. C. Y.

    Published in Alimentary pharmacology & therapeutics (01-06-2003)
    “…Summary Background and aims: To develop a validated gastro‐oesophageal disease (GERD) symptom questionnaire for the Chinese population. Methods: One hundred…”
    Get full text
    Journal Article
  17. 17

    Review article: current management of metastatic colorectal cancer – the evolving impact of targeted drug therapies by YAU, T., CHAN, P., Ching CHAN, Y., WONG, B. C. Y., LIANG, R., EPSTEIN, R. J.

    Published in Alimentary pharmacology & therapeutics (01-06-2008)
    “…Summary Background  The field of colorectal cancer chemotherapy has been transformed by the advent of molecule‐specific drugs. Combined use of such drugs…”
    Get full text
    Journal Article
  18. 18

    Clinical trial: levofloxacin‐based quadruple therapy was inferior to traditional quadruple therapy in the treatment of resistant Helicobacter pylori infection by YEE, Y. K., CHEUNG, T. K., CHU, K.‐M., CHAN, C. K., FUNG, J., CHAN, P., BUT, D., HUNG, I., CHAN, A. O. O., YUEN, M. F., HSU, A., WONG, B. C. Y.

    Published in Alimentary Pharmacology and Therapeutics (01-10-2007)
    “…Summary Background  The efficacy of levofloxacin‐based quadruple therapy in resistant Helicobacter pylori infection is not known. Aim  To test the efficacy of…”
    Get full text
    Journal Article
  19. 19

    Lansoprazole reduces ulcer relapse after eradication of Helicobacter pylori in nonsteroidal anti‐inflammatory drug users – a randomized trial by Lai, K. C., Lam, S. K., Chu, K. M., Hui, W. M., Kwok, K. F., Wong, B. C. Y., Hu, H. C., Wong, W. M., Chan, O. O., Chan, C. K.

    Published in Alimentary pharmacology & therapeutics (15-10-2003)
    “…Summary Aim : To study whether prophylaxis with lansoprazole could prevent relapse of ulcers after eradication of Helicobacter pylori in patients with…”
    Get full text
    Journal Article
  20. 20

    A sensitive guaiac faecal occult blood test is less useful than an immunochemical test for colorectal cancer screening in a Chinese population by Wong, B. C.‐Y., Wong, W. M., Cheung, K. L., Tong, T. S. M., Rozen, P., Young, G. P., Chu, K. W., Ho, J., Law, W. L., Tung, H. M., Lai, K. C., Hu, W. H. C., Chan, C. K., Lam, S. K.

    Published in Alimentary pharmacology & therapeutics (01-11-2003)
    “…Summary Background : Colorectal cancer screening by guaiac faecal occult blood test has been shown to reduce the incidence and mortality of colorectal cancer…”
    Get full text
    Journal Article